. . . . . . . "[For patients with chronic myeloid leukaemia (CML), current guidelines advocate frequent monitoring using haematological, cytogenetic, and molecular methods, and these have been used to set targets for disease responses at various time points.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2017-02-19"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2017-10-17T13:16:10+02:00"^^ . . . . . . . . . . . "v5.0.0.0" . "v5.0.0" .